1. Home
  2. Knowledge Base
  3. References
  4. The embryotoxic effects of harm reduction tobacco products on osteoblasts developing from human embryonic stem cells

The embryotoxic effects of harm reduction tobacco products on osteoblasts developing from human embryonic stem cells

Sparks NR (2018) The embryotoxic effects of harm reduction tobacco products on osteoblasts developing from human embryonic stem cells. University of California Riverside Thesis.

Objective: To investigate the effect of maternal smoking in the development of embryonic skeleton and the molecular mechanisms involved in skeletal embryotoxicity induced by conventional and harm-reduction tobacco.

Summary: An in vitro model based on human embryonic stem cells was developed, that mimics the development of the human embryo; their differentiation into osteoblasts in vitro can be used to study chemical toxicity and the molecular mechanisms thereof. Tobacco-induced oxidative stress disrupts osteogenic differentiation in human embryonic stem cells.

Usage: Immunocytochemistry

Related Products: NGFR (mu p75) Rabbit Polyclonal, affinity-purified (Cat. #AB-N01AP)

Shopping Cart
Scroll to Top